[Value of fluorine-18 fluorode oxyglucose-positron emission tomography in patients with small cell lung cancer].
OBJECTIVE
To investigate the value of fluorine-18 fluorodeoxyglucose (FDG)-positron emission tomography (PET) imaging in patients with small cell lung cancer.


METHODS
From February 2000 to July 2003, 17 patients with small cell lung cancer were imaged with FDG-PET. FDG-PET scans were analyzed by visual method. The FDG-PET results were compared with the pathological results and results of follow-up survey.


RESULTS
15 primary tumors were all FDG avid. By visual method 63 areas metastatic lymph nodes in 15 cases were revealed and more distant metastases outside the hemithoraxes were confirmed by FDG-PET than by routine examinations. FDG-PET corrected the diagnosis 5 cases from local disease (LD) to extended disease (ED).


CONCLUSIONS
FDG-PET has great value in staging and treatment of patients with small cell lung cancer.
Yu
Chang-hai
CH
Department of Thoracic Surgery, General Hospital of PLA, Beijing 100853, China.
Wang
Tao
T
Yin
Da-yi
DY
Sun
Yu-e
YE
Tian
Jia-he
JH
Yao
Shu-lin
SL
D000368:Aged; D000369:Aged, 80 and over; D018288:Carcinoma, Small Cell / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D014055:Tomography, Emission-Computed
D019788:Fluorodeoxyglucose F18